Mesuximide (or methsuximide) is an anticonvulsant medication. It is sold by Pfizer under the name Petinutin.
For the control of absence (petit mal) seizures that are refractory to other drugs.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.